Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s GSK GSK Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-201,301	Closed	-$7.82M	–	62
2025 Q2	$7.82M	Hold	201,301	–	–	0.57%	45
2025 Q1	$7.87M	Sell	201,301 -135,314	-40%	-$4.95M	0.64%	43
2024 Q4	$11.6M	Buy	+336,615	New	+$12.1M	0.91%	41

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's GSK Position: Q3 2025 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of GSK (GSK) in Q3 2025, closing a stake of 201,301 shares — an estimated $7.82M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in GSK in Q4 2024 and held it in 3 quarters. The position peaked at $11.6M in Q4 2024. 896 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 201,301 GSK shares in Q3 2025, an estimated $7.82M.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in GSK in Q4 2024 and held it in 3 quarters.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's GSK position peaked at $11.6M in Q4 2024.
896 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q3 2025, filed 5 Nov 2025.